Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)
Clinical trial NCT02676349 · COMPLETED
Trial details
- NCT number
- NCT02676349
- Sponsor
- Institut de Cancérologie de Lorraine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-13
- Primary completion
- 2024-04-19
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.